highly significantp = 0.0006
A comparison of the mEHT-treated and nontreated patients with the same stage brain tumors in the same research group in Italy [ 74 ] showed a highly significant ( p = 0.0006) response rate compared to the conventional control and also for GBM ( p = 0.026).